SCHEMBL15065746

SCHEMBL15065746

CN(C)CCN1CCN(CCN2CCN(C)CC2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.38
PAOX Q6QHF9 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
PTK2B Q14289 1/20 0.36
ESR2 Q92731 1/20 0.36
SIGMAR1 Q99720 8/20 0.35
KDM1A O60341 1/20 0.35
CA12 O43570 1/20 0.35
CA2 P00918 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA5B Q9Y2D0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL134397 0.97 PIM1 (0.39) PIM1PAOXKDM4EALDH1A1LMNA
SCHEMBL14142584 0.97 PIM1 (0.39) PIM1PAOXKDM4EALDH1A1LMNA
SCHEMBL19212956 0.97 PIM1 (0.39) PIM1PAOXKDM4EALDH1A1LMNA
Hydrochloric Acid SCHEMBL8203320 0.95 PIM1 (0.38) PIM1PAOXKDM4EALDH1A1LMNA
Hydrochloric Acid SCHEMBL7648633 0.93 PIM1 (0.37) PIM1PAOXKDM4EALDH1A1LMNA
Hydrochloric Acid SCHEMBL7648636 0.93 PIM1 (0.37) PIM1PAOXKDM4EALDH1A1LMNA
SCHEMBL3418369 0.91 PIM1 (0.36) PIM1PAOXKDM4EALDH1A1LMNA
SCHEMBL1186740 0.89
SCHEMBL2231151 0.89 PIM1 (0.42) PIM1KDM4EALDH1A1LMNAMAPT
SCHEMBL2920396 0.89 CHKA (0.43) SIGMAR1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9644066-B2 Cyclic amine compounds, compositions, and polyurethane foams made therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2017-05-09 US claimed
EP-2797902-B1 COMPOSITIONS CONTAINING CYCLIC AMINE COMPOUNDS, AND POLYURETHANE FOAMS MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2017-04-26 EP claimed
US-20150005404-A1 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC 2015-01-01 US claimed
EP-2797902-A2 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM Dow Global Technologies LLC (US) 2014-11-05 EP claimed
WO-2013102097-A2 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2013-07-04 WO claimed
US-9644066-B2 Cyclic amine compounds, compositions, and polyurethane foams made therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2017-05-09 US disclosed
EP-2797902-B1 COMPOSITIONS CONTAINING CYCLIC AMINE COMPOUNDS, AND POLYURETHANE FOAMS MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2017-04-26 EP disclosed
US-20150005404-A1 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC 2015-01-01 US disclosed
EP-2797902-A2 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM Dow Global Technologies LLC (US) 2014-11-05 EP disclosed
WO-2013102097-A2 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2013-07-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005404-A1 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM PUF60, UFM1, POLM PIM1 3314/4885PAOX 886/4885KDM4E 1785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.